• GeoVax Labs entered warrant inducement agreement with existing institutional investors for immediate exercise of existing warrants for up to 501,144 common shares.
• Transaction expected to raise about USD 595,000 in gross proceeds; net proceeds earmarked for working capital and general corporate purposes.
• Investors to receive new unregistered warrants for up to 1,002,288 shares; exercise price set at USD 1.65.
• New warrants become exercisable once shareholder approval is obtained; expiry set for five years from approval date.
• Closing expected on or about May 8, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-015613), on May 07, 2026, and is solely responsible for the information contained therein.